|
1
|
Tzouvelekis A, Koliakos G, Ntolios P,
Baira I, Bouros E, Oikonomou A, Zissimopoulos A, Kolios G, Kakagia
D, Paspaliaris V, et al: Stem cell therapy for idiopathic pulmonary
fibrosis: a protocol proposal. J Transl Med. 9:1822011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'Agostino B, Sullo N, Siniscalco D, De
Angelis A and Rossi F: Mesenchymal stem cell therapy for the
treatment of chronic obstructive pulmonary disease. Expert Opin
Biol Ther. 10:681–687. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang WG, He L, Shi XM, Wu SS, Zhang B,
Mei L, Xu YJ, Zhang ZX, Zhao JP and Zhang HL: Regulation of
transplanted mesenchymal stem cells by the lung progenitor niche in
rats with chronic obstructive pulmonary disease. Respir Res.
15:332014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moodley Y, Atienza D, Manuelpillai U,
Samuel CS, Tchongue J, Ilancheran S, Boyd R and Trounson A: Human
umbilical cord mesenchymal stem cells reduce fibrosis of
bleomycin-induced lung injury. Am J Pathol. 175:303–313. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta N, Su X, Popov B, Lee JW, Serikov V
and Matthay MA: Intrapulmonary delivery of bone marrow-derived
mesenchymal stem cells improves survival and attenuates
endotoxin-induced acute lung injury in mice. J Immunol.
179:1855–1863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taghi GM, Ghasem Kashani Maryam H, Taghi
L, Leili H and Leyla M: Characterization of in vitro cultured bone
marrow and adipose tissue-derived mesenchymal stem cells and their
ability to express neurotrophic factors. Cell Biol Int.
36:1239–1249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakao N, Nakayama T, Yahata T, Muguruma Y,
Saito S, Miyata Y, Yamamoto K and Naoe T: Adipose tissue-derived
mesenchymal stem cells facilitate hematopoiesis in vitro and in
vivo: advantages over bone marrow-derived mesenchymal stem cells.
Am J Pathol. 177:547–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding L, Dolgachev V, Wu Z, Liu T,
Nakashima T, Wu Z, Ullenbruch M, Lukacs NW, Chen Z and Phan SH:
Essential role of stem cell factor-c-Kit signalling pathway in
bleomycin-induced pulmonary fibrosis. J Pathol. 230:205–214. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu HY, Chiou JF, Wu AT, Tsai CY, Leu JD,
Ting LL, Wang MF, Chen HY, Lin CT, Williams DF, et al: The effect
of diminished osteogenic signals on reduced osteoporosis recovery
in aged mice and the potential therapeutic use of adipose-derived
stem cells. Biomaterials. 33:6105–6112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hattori N, Degen JL, Sisson TH, Liu H,
Moore BB, Pandrangi RG, Simon RH and Drew AF: Bleomycin-induced
pulmonary fibrosis in fibrinogen-null mice. J Clin Invest.
106:1341–1350. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Monteiro-Amado F, Castro-Silva II, Lima
CJ, Soares FA, Kowalski LP and Granjeiro JM: Immunohistochemical
evaluation of MMP-2, MMP-9 and CD31/microvascular density in
squamous cell carcinomas of the floor of the mouth. Braz Dent J.
24:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Inamdar AC and Inamdar AA: Mesenchymal
stem cell therapy in lung disorders: pathogenesis of lung diseases
and mechanism of action of mesenchymal stem cell. Exp Lung Res.
39:315–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moodley Y, Manuelpillai U and Weiss DJ:
Cellular therapies for lung disease: a distant horizon.
Respirology. 16:223–237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sdrimas K and Kourembanas S: MSC
microvesicles for the treatment of lung disease: a new paradigm for
cell-free therapy. Antioxid Redox Signal. 21:1905–1915. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huleihel L, Levine M and Rojas M: The
potential of cell-based therapy in lung diseases. Expert Opin Biol
Ther. 13:1429–1440. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhieu BH, Epperly MW, Cao S, Franicola D,
Shields D, Goff J, Wang H and Greenberger JS: Increased
hematopoiesis in long-term bone marrow cultures and reduced
irradiation-induced pulmonary fibrosis in Von Willebrand factor
homologous deletion recombinant mice. In Vivo. 28:449–456.
2014.PubMed/NCBI
|
|
17
|
Gilpin SE, Lung K, de Couto GT, Cypel M,
Sato M, Singer LG, Keshavjee S and Waddell TK: Bone marrow-derived
progenitor cells in end-stage lung disease patients. BMC Pulm Med.
13:482013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguilar S, Scotton CJ, McNulty K, Nye E,
Stamp G, Laurent G, Bonnet D and Janes SM: Bone marrow stem cells
expressing keratinocyte growth factor via an inducible lentivirus
protects against bleomycin-induced pulmonary fibrosis. PLoS One.
4:e80132009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalayarasan S, Sriram N, Soumyakrishnan S
and Sudhandiran G: Diallylsulfide attenuates excessive collagen
production and apoptosis in a rat model of bleomycin induced
pulmonary fibrosis through the involvement of protease activated
receptor-2. Toxicol Appl Pharmacol. 271:184–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rawlins EL: Lung epithelial progenitor
cells: lessons from development. Proc Am Thorac Soc. 5:675–681.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reynolds SD and Malkinson AM: Clara cell:
progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol.
42:1–4. 2010. View Article : Google Scholar
|
|
22
|
Popova AP, Bozyk PD, Goldsmith AM, Linn
MJ, Lei J, Bentley JK and Hershenson MB: Autocrine production of
TGF-beta1 promotes myofibroblastic differentiation of neonatal lung
mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol.
298:L735–L743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun Z, Wang C, Shi C, Sun F, Xu X, Qian W,
Nie S and Han X: Activated Wnt signaling induces myofibroblast
differentiation of mesenchymal stem cells, contributing to
pulmonary fibrosis. Int J Mol Med. 33:1097–1109. 2014.PubMed/NCBI
|
|
24
|
Lagente V, Manoury B, Nénan S, Le Quément
S, Martin-Chouly C and Boichot E: Role of matrix metalloproteinases
in the development of airway inflammation and remodeling. J Med
Biol Res. 38:1521–1530. 2005. View Article : Google Scholar
|
|
25
|
Kim JY, Choeng HC, Ahn C and Cho SH: Early
and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary
fibrosis. Yonsei Med J. 50:68–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Q, Zhu H, Zhou WG, Guo XC, Wu MJ, Xu
ZY, Jiang JF, Shen C and Liu HQ: N-acetylcysteine-pretreated human
embryonic mesenchymal stem cell administration protects against
bleomycin-induced lung injury. Am J Med Sci. 346:113–122. 2013.
View Article : Google Scholar
|
